BMY vs KD · P/E 17, rev $24.46B vs P/E 14, rev $15.09B
Bristol-Myers Squibb Company (BMY) versus Kyndryl Holdings Inc (KD) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Kyndryl Holdings Inc (KD) is a information technology services company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported KD revenue for 2026-03-31 was $15.09B. Net income was $198.0M. Revenue was up 0.2% from 2025-03-31 to 2026-03-31. KD currently screens at market cap $2.69B and trailing P/E 14.4.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. KD currently screens at market cap $2.69B and trailing P/E 14.4.
Not investment advice. Open the BMY and KD stock pages for the full models.
Not investment advice.